Abstract
KCa3.1 protein is part of a heterotetrameric voltage-independent potassium channel, the activity of which depends on the intracellular calcium binding to calmodulin. KCa3.1 is immensely significant in regulating immune responses and primarily expressed in cells of hematopoietic lineage. It is one of the attractive pharmacological targets that are known to inhibit neuroinflammation. KCa3.1 blockers mediate neuroprotection through multiple mechanisms, such as by targeting microglia-mediated neuronal killing. KCa3.1 modulators may provide alternative treatment options for neurological disorders like ischemic stroke, Alzheimer disease, glioblastoma multiforme, multiple sclerosis and spinal cord injury. This review is an attempt to draw attention towards KCa3.1 channel, which was never exploited to its full potential as a viable therapeutic candidate against various neurological disorders.
Keywords: Alzheimer disease, glioblastoma multiforme, ischemic stroke, KCa3.1, KCNN4, multiple sclerosis.
CNS & Neurological Disorders - Drug Targets
Title:Role of KCa3.1 Channels in CNS Diseases: A Concise Review
Volume: 15 Issue: 10
Author(s): Sinoy Sugunan, Sreekala S. Nampoothiri, Tanya Garg and Rajanikant G. Krishnamurthy
Affiliation:
Keywords: Alzheimer disease, glioblastoma multiforme, ischemic stroke, KCa3.1, KCNN4, multiple sclerosis.
Abstract: KCa3.1 protein is part of a heterotetrameric voltage-independent potassium channel, the activity of which depends on the intracellular calcium binding to calmodulin. KCa3.1 is immensely significant in regulating immune responses and primarily expressed in cells of hematopoietic lineage. It is one of the attractive pharmacological targets that are known to inhibit neuroinflammation. KCa3.1 blockers mediate neuroprotection through multiple mechanisms, such as by targeting microglia-mediated neuronal killing. KCa3.1 modulators may provide alternative treatment options for neurological disorders like ischemic stroke, Alzheimer disease, glioblastoma multiforme, multiple sclerosis and spinal cord injury. This review is an attempt to draw attention towards KCa3.1 channel, which was never exploited to its full potential as a viable therapeutic candidate against various neurological disorders.
Export Options
About this article
Cite this article as:
Sugunan Sinoy, Nampoothiri S. Sreekala, Garg Tanya and Krishnamurthy G. Rajanikant, Role of KCa3.1 Channels in CNS Diseases: A Concise Review, CNS & Neurological Disorders - Drug Targets 2016; 15 (10) . https://dx.doi.org/10.2174/1871527315666160822111913
DOI https://dx.doi.org/10.2174/1871527315666160822111913 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain-Derived Neurotrophic Factor and Antidepressant Activity
Current Pharmaceutical Design Therapeutic Potential of Vitamin D for Multiple Sclerosis
Current Medicinal Chemistry Seeing the Person in the Patient: Making the Case for Individualized PROMs in Mental Health Care
Current Psychiatry Reviews The Differences in Neural Response to Faces and Non-Faces in the FFA: Evidence from the Central to Peripheral Visual Field
Neuroscience and Biomedical Engineering (Discontinued) Editorial (Hot Topic: Artificial Intelligence Techniques in Medicinal Chemistry)
Current Topics in Medicinal Chemistry Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors
Current Drug Safety Current Drug Targets for Thymic Neoplasms
Current Cancer Drug Targets WNT Signaling in Stem Cell Biology and Regenerative Medicine
Current Drug Targets The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Mitochondrial Dysfunction in Blood Platelets of Patients with Manic Episode of Bipolar Disorder
CNS & Neurological Disorders - Drug Targets Zebrafish Model in Drug Safety Assessment
Current Pharmaceutical Design Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine Cytokine Antibody Arrays in Biomarker Discovery and Validation
Current Proteomics Nutritional Quality of Lettuce
Current Nutrition & Food Science Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance
CNS & Neurological Disorders - Drug Targets Physiotherapy for Ankylosing Spondylitis: Systematic Review and a Proposed Rehabilitation Protocol
Current Rheumatology Reviews In Vivo Cellular Imaging for Translational Medical Research
Current Medical Imaging Modulation Effects of Piracetam and Ginkgo biloba on the Cognitive and Working Memory Functions: Psychometric Study
Current Psychopharmacology Current Methods in the Automatic Tissue Segmentation of 3D Magnetic Resonance Brain Images
Current Medical Imaging